Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Sinusitis

para />
  • Sinuses are not fully developed until age 20 years. Maxillary and ethmoid sinuses, although small, are present from birth.

  • Because children have an average of six to eight colds per year, they are at risk for developing sinusitis.

  • Diagnosis can be more difficult than in adults because symptoms are often more subtle.

 

DIFFERENTIAL DIAGNOSIS


  • Dental disease
  • CF
  • Wegener granulomatosis
  • HIV infection
  • Kartagener syndrome
  • Neoplasm
  • Headache, tension, or migraine

DIAGNOSTIC TESTS & INTERPRETATION


Diagnostic tests are not routinely recommended; no diagnostic tests can adequately differentiate between viral and bacterial rhinosinusitis (2)[C].  
  • None indicated in routine evaluation
  • Routine use of sinus radiography discouraged because of the following:
    • ≥3 clinical findings have similar diagnostic accuracy as imaging.
    • Imaging does not distinguish viral from bacterial etiology.
  • Limited coronal CT scan can be useful in recurrent infection or failure to respond to medical therapy.

Diagnostic Procedures/Other
Sinus CT if signs suggest extrasinus involvement or to evaluate chronic rhinosinusitis  
Test Interpretation
  • Inflammation, edema, thickened mucosa
  • Impaired ciliary function
  • Metaplasia of ciliated columnar cells
  • Relative acidosis and hypoxia within sinuses
  • Polyps

TREATMENT


Most cases resolve with supportive care (treating pain, nasal symptoms). Antibiotics should be reserved for symptoms that persist >10 days, onset with severe symptoms (high fever, purulent nasal discharge, facial pain) for at least 3 to 4 consecutive days, or worsening signs/symptoms that were initially improving (1,2)[C].  

GENERAL MEASURES


  • Hydration
  • Steam inhalation 20 to 30 minutes TID
  • Saline irrigation (Neti pot) or nose drops
  • Sleep with head of bed elevated.
  • Avoid exposure to cigarette smoke or fumes.
  • Avoid caffeine and alcohol.
  • Antibiotics are indicated only when findings suggest bacterial infection.
  • Analgesics, NSAIDs
  • Acute viral sinusitis is self-limiting; antibiotics should not be used.

MEDICATION


First Line
  • Decongestants
    • Pseudoephedrine HCl
    • Phenylephrine nasal spray (limited use)
    • Oxymetazoline nasal spray (e.g., Afrin) (not to be used >3 days)
  • Analgesics
    • Acetaminophen
    • Aspirin
    • NSAIDs
  • Antibiotics
    • Antibiotics have a slight advantage over placebo at 7 to 14 days (3)[A], yet most improve without therapy.
    • Reserve antibiotic use for patients with moderate to severe disease.
    • Choice should be based on understanding of antibiotic resistance in the community.
    • Infectious Disease Society of America recommends the following (1)[C]:
      • Start antibiotics as soon as clinical diagnosis of acute bacterial sinusitis is made.
      • Use amoxicillin-clavulanate rather than amoxicillin alone.
      • Amoxicillin-clavulanate 875/125 mg q12h; 2 g orally BID in geographic regions with high rates of resistant S. pneumoniae
      • Doxycycline: 100 mg PO BID an alternative to amoxicillin-clavulanate for initial therapy (adults only)
      • Trimethoprim-sulfamethoxazole (TMP/SMX) and 3rd generation cephalosporins not recommended due to high rate of resistance (1)[C]
      • Treat for 5 to 7 days in adults if uncomplicated bacterial rhinosinusitis (IDSA low-moderate-quality evidence). Treat for 10 to 14 days in children if uncomplicated bacterial rhinosinusitis (IDSA low-moderate-quality evidence).
    • American Academy of Pediatrics recommends the following (1)[C]:
      • Amoxicillin: 45 to 90 mg/kg/day in 2 divided doses if uncomplicated acute bacterial sinusitis in children
      • Amoxicillin-clavulanate: 80 to 90 mg/6.4 mg/kg/day in 2 divided doses for children with severe illness, recent antibiotics, or attending daycare
      • Levofloxacin: 10 to 20 mg/kg/day max 750mg/day if history of type 1 hypersensitivity to PCN (1)[C]
      • Clindamycin (30 to 40 mg/kg/day) + cefixime (8mg/kg/day in 2 divided doses) or cefpodoxime (10 mg/kg/day in 2 divided doses) (1)[C] for non-type 1 PCN allergy
      • Ceftriaxone: 50 mg/kg IM single dose if not able to tolerate oral meds (4)[C]
  • Because allergies may be a predisposing factor, some patients may benefit from use of the following agents:
    • Oral antihistamines
      • Loratadine (Claritin), fexofenadine (Allegra), cetirizine (Zyrtec), desloratadine (Clarinex), or levocetirizine (Xyzal)
      • Chlorpheniramine (Chlor-Trimeton)
      • Diphenhydramine (Benadryl)
    • Leukotriene inhibitors (Singulair, Accolate), especially in patients with asthma
    • Nasal steroids (i.e., fluticasone [Flonase])

Second Line
  • Levofloxacin (Levaquin): 750 mg/day for 5 days or moxifloxacin 400 mg/day for 5 to 7 days (adults only) (1)[C]
  • If no response to first-line therapy after 72 hours
    • Broaden antibiotic coverage or switch to a different class, evaluate for resistant pathogens or other causes for treatment failure (i.e., noninfectious etiology) fluoroquinolones as above.
  • Note: Bacteriologic failure rates of up to 20-25% are possible with use of azithromycin and clarithromycin.
  • If lack of response to 3 weeks of antibiotics, consider the following:
    • CT scan of sinuses
    • Ear/nose/throat (ENT) referral

ISSUES FOR REFERRAL


Complications or failure of treatment  
ALERT

  • Meta-analyses have demonstrated no benefit of newer antibiotics over amoxicillin or doxycycline.

  • Antibiotics recommendations vary with different guidelines. Patients seen by specialists are different from those in a primary care setting. Patients usually do not have complicated sinusitis in primary care setting.

    • American Academy of Otolaryngology-Head and Neck Surgery Foundation (2)[C] recommends the following:

      • Consider watchful waiting without antibiotics in patients with uncomplicated mild illness (mild pain and temperature <101 °F) with assurance of follow-up within 7 days.

  • PCV-13 pneumococcal vaccine can be helpful in reducing chronic sinusitis in children (5)[B].

  • Use of intranasal steroids small but significant improvement in symptoms when used alone or in combination with antibiotics (6)[A].

  • Precautions

    • Decongestants can exacerbate hypertension.

    • Intranasal decongestants should be limited to 3 days to avoid rebound nasal congestion.

 
Pregnancy Considerations

  • Nasal irrigation with saline, pseudoephedrine, most antihistamines, and some nasal steroids are safe during pregnancy and lactation.

  • Antibiotics safe in pregnancy and lactation

    • Amoxicillin, amoxicillin-clavulanate, cephalosporins

  • Antibiotic contraindicated: doxycycline, fluoroquinolones

  • Antibiotic safe in lactation but not pregnancy: levofloxacin

 

SURGERY/OTHER PROCEDURES


  • If medical therapy fails, consider sinus irrigation.
  • Functional endoscopic sinus surgery is the preferred treatment for medically recalcitrant cases.
  • Absolute surgical indications
    • Massive nasal polyposis
    • Acute complications: subperiosteal or orbital abscess, frontal soft tissue spread of infection
    • Mucocele or mucopyocele
    • Invasive or allergic fungal sinusitis
    • Suspected obstructing tumor
    • CSF rhinorrhea

INPATIENT CONSIDERATIONS


Hospitalization for complications (e.g., meningitis, orbital cellulitis or abscess, brain abscess)  

ONGOING CARE


FOLLOW-UP RECOMMENDATIONS


Return if no improvement after 72 hours or no resolution of symptoms after 10 days of antibiotics.  

PATIENT EDUCATION


  • http://familydoctor.org/familydoctor/en.html
  • https://www.nlm.nih.gov/medlineplus/

PROGNOSIS


Alleviation of symptoms within 72 hours with complete resolution within 10 to 14 days  

COMPLICATIONS


  • Serious complications are rare.
  • Meningitis, orbital cellulitis, brain abscess
  • Cavernous sinus thrombosis
  • Osteomyelitis, subdural empyema

REFERENCES


11 Chow  AW, Benninger  MS, Brook  I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis.  2012;54(8):e72-e112.22 Rosenfeld  RM, Piccirillo  JF, Chandrasekhar  SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg.  2015;152(2 Suppl):S1-S39.33 Ahovuo-Saloranta  A, Rautakorpi  UM, Borisenko  OV, et al. Antibiotics for acute maxillary sinusitis in adults. Cochrane Database Syst Rev.  2014;(2):CD000243.44 Wald  ER, Applegate  KE, Bordley  C, et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics.  2013;132(1):e262-e280.55 Olarte  L, Hulten  KG, Lamberth  L, et al. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J.  2014;33(10):1033-1036.66 Hayward  G, Heneghan  C, Perera  R, et al. Intranasal corticosteroids in management of acute sinusitis: a systematic review and meta-analysis. Ann Fam Med.  2012;10(3):241-249.

ADDITIONAL READING


  • Aring  AM, Chan  MM. Acute rhinosinusitis in adults. Am Fam Physician.  2011;83(9):1057-1063.
  • Centers for Disease Control and Prevention. Get Smart: homepage. http://www.cdc.gov/getsmart/.
  • Williams  JWJr, Aguilar  C, Cornell  J, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev.  2003;(2):CD000243.
  • Wilson  JF. In the clinic. Acute sinusitis. Annal Intern Med.  2010;153(5):ITC3-1-ITC3-15.

CODES


ICD10


  • J01.90 Acute sinusitis, unspecified
  • J01.00 Acute maxillary sinusitis, unspecified
  • J01.20 Acute ethmoidal sinusitis, unspecified
  • J32.9 Chronic sinusitis, unspecified
  • J32.8 Other chronic sinusitis
  • J32.4 Chronic pansinusitis
  • J32.3 Chronic sphenoidal sinusitis
  • J32.2 Chronic ethmoidal sinusitis
  • J32.1 Chronic frontal sinusitis
  • J32.0 Chronic maxillary sinusitis
  • J01.91 Acute recurrent sinusitis, unspecified
  • J01.81 Other acute recurrent sinusitis
  • J01.80 Other acute sinusitis
  • J01.41 Acute recurrent pansinusitis
  • J01.40 Acute pansinusitis, unspecified
  • J01.31 Acute recurrent sphenoidal sinusitis
  • J01.30 Acute sphenoidal sinusitis, unspecified
  • J01.21 Acute recurrent ethmoidal sinusitis
  • J01.10 Acute frontal sinusitis, unspecified
  • J01.01 Acute recurrent maxillary sinusitis
  • J01.11 Acute recurrent frontal sinusitis

ICD9


  • 473.9 Unspecified sinusitis (chronic)
  • 461.9 Acute sinusitis, unspecified
  • 461.0 Acute maxillary sinusitis
  • 461.2 Acute ethmoidal sinusitis
  • 461.8 Other acute sinusitis
  • 473.0 Chronic maxillary sinusitis
  • 473.1 Chronic frontal sinusitis
  • 473.2 Chronic ethmoidal sinusitis
  • 473.3 Chronic sphenoidal sinusitis
  • 473.8 Other chronic sinusitis
  • 461.3 Acute sphenoidal sinusitis

SNOMED


  • 36971009 Sinusitis (disorder)
  • 15805002 Acute sinusitis (disorder)
  • 68272006 Acute maxillary sinusitis (disorder)
  • 67832005 Acute ethmoidal sinusitis
  • 73237007 Chronic ethmoidal sinusitis
  • 40055000 Chronic sinusitis (disorder)
  • 38961000 Chronic sphenoidal sinusitis
  • 35923002 Chronic maxillary sinusitis
  • 77919000 Acute sphenoidal sinusitis
  • 60130002 Chronic frontal sinusitis

CLINICAL PEARLS


  • When bacterial infection is present, patients recover somewhat more quickly with antibiotics, but the majority will recover with symptomatic treatment alone, and accurate diagnosis of bacterial sinusitis is very difficult.
  • Multiple meta-analyses have demonstrated no benefit of newer antibiotics over amoxicillin or doxycycline.
  • Overall NNT to prevent 1 persistent case at follow-up = 15; harm due to antibiotic-associated diarrhea is similar.
  • Significant patient symptom relief with nasal saline spray or drops or irrigation (Neti pot)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer